Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

NCT05432739 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT05432739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
April 7, 2021
Completion date
January 1, 2031
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer